Dublin, Feb. 04, 2019 (GLOBE NEWSWIRE) -- The "Creatinine Measurement - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Global Creatinine Measurement market accounted for $330.90 million in 2017 and is expected to reach $745.00 million by 2026 growing at a CAGR of 9.4% during the forecast period.

The growing renal functioning disorder and increasing geriatric population are driving the market. However, often changing regulatory policies and recognition of novel renal dysfunction biomarkers are hampering the market growth. Moreover, commercialization of sophisticated testing methods is providing ample opportunity for the growth of the market.

Creatinine measurement is the process of measuring creatinine. Creatinine is a waste product that is obtained from the human body due to the general breakdown of muscle tissues. The creatinine produced in the body is then filtered using kidneys. The basic kidney test carried out is analyzed using the creatinine levels in the blood.

Based on the sample, blood/ serum segment is attributed to observe ample growth opportunities, as most of the creatinine measurement kits and reagents are based on the analysis of creatinine in blood samples due to its accurateness in inferring creatinine concentration and less menace of contamination. These benefits are liable for the growing acceptance of the blood/serum sample for the measurement of creatinine levels.

By geography, North America acquired largest market share owing to the factors such as rising occurrence of renal disorders, increasing the prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction) in the region and the implementation of favorable management initiatives to raise awareness about kidney diseases and their untimely diagnosis.

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 9 years of all the mentioned segments, and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.5 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Creatinine Measurement Market, By Type
5.1 Introduction
5.2 Jaffe'S Kinetic Method
5.3 Enzymatic Method

6 Global Creatinine Measurement Market, By Product
6.1 Introduction
6.2 Kits
6.3 Reagents

7 Global Creatinine Measurement Market, By Sample
7.1 Introduction
7.2 Blood/Serum
7.3 Urine

8 Global Creatinine Measurement Market, By End User
8.1 Introduction
8.2 Diagnostic Laboratories
8.3 Hospitals

9 Global Creatinine Measurement Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Siemens Healthineers
11.2 Abbott Laboratories (US)
11.3 Diazyme Laboratories, Inc.
11.4 Wako Pure Chemical Industries Ltd.
11.5 Randox Laboratories
11.6 Danaher Corporation (US)
11.7 Pointe Scientific
11.8 Thermo Fisher Scientific Inc
11.9 Ortho Clinical Diagnostics
11.10 F. Hoffmann-la Roche Ltd (Switzerland)
11.11 Roche
11.12 Dialab GmbH (Vienna)
11.13 Sentinel Ch. Spa. (Italy)
11.14 Diasys Diagnostic Systems GmbH (Germany)

For more information about this report visit https://www.researchandmarkets.com/research/8bpdvj/creatinine?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics